Interesting Article from MDLinx
Click the title below to leave the MDLinx Network and go to the Journal's Website
Assessing the efficacy of 2 years of maintenance treatment with venlafaxine
extended release 75-225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT studyInternational Clinical Psychopharmacology, 11/07/08
| Kornstein SG et al. - Venlafaxine ER effectively maintained response at doses <=225 mg/day for up to 2.5 years in patients with recurrent
MDD. |
No comments:
Post a Comment